Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is OMEPRAZOLE USP, with a corresponding US DMF Number 29633.
Remarkably, this DMF maintains an Active status since its submission on October 21, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 21, 2016, and payment made on October 21, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II